A detailed history of Wolverine Trading, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 6,841 shares of CRL stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,841
Previous 6,700 2.1%
Holding current value
$1.35 Million
Previous $1.38 Million 2.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $1.29 Million - $1.68 Million
6,841 New
6,841 $1.35 Million
Q4 2023

Feb 14, 2024

BUY
$164.52 - $238.84 $426,929 - $619,789
2,595 New
2,595 $613,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $316,168 - $434,185
1,733 New
1,733 $329,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $1.1 Million - $1.56 Million
-4,315 Reduced 77.36%
1,263 $366,000
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $814,850 - $1.04 Million
2,319 Added 71.16%
5,578 $2.1 Million
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $1.06 Million - $1.3 Million
-2,832 Reduced 46.49%
3,259 $1.38 Million
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $816,321 - $1.03 Million
2,775 Added 83.69%
6,091 $2.26 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $518,065 - $621,421
2,075 Added 167.2%
3,316 $955,000
Q3 2020

Nov 13, 2020

SELL
$175.56 - $226.45 $1.39 Million - $1.79 Million
-7,901 Reduced 86.43%
1,241 $277,000
Q1 2020

May 11, 2020

BUY
$98.9 - $178.34 $586,773 - $1.06 Million
5,933 Added 184.89%
9,142 $1.19 Million
Q4 2019

Feb 12, 2020

BUY
$126.05 - $152.76 $404,494 - $490,206
3,209 New
3,209 $487,000
Q3 2018

Nov 14, 2018

SELL
$112.11 - $134.54 $271,306 - $325,586
-2,420 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$98.19 - $115.2 $237,619 - $278,784
2,420 New
2,420 $258,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.